PROCEPT BioRobotics (PRCT) Revenue Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 16.70% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 7.41% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 15.05% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 6.08% |
| 10 | PROCEPT BioRobotics | 978.77 Mn | 733.13 Mn | 53.95 Mn | 20.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.20% |
| Dec 31, 2025 | 11.94% |
| Sep 30, 2025 | 42.76% |
| Jun 30, 2025 | 48.41% |
| Mar 31, 2025 | 55.28% |
| Dec 31, 2024 | 56.57% |
| Sep 30, 2024 | 66.29% |
| Jun 30, 2024 | 61.17% |
| Mar 31, 2024 | 82.51% |
| Dec 31, 2023 | 83.29% |
| Sep 30, 2023 | 72.50% |
| Jun 30, 2023 | 98.33% |
| Mar 31, 2023 | 71.90% |
| Dec 31, 2022 | 134.53% |
| Sep 30, 2022 | 134.76% |
| Jun 30, 2022 | 96.92% |
| Mar 31, 2022 | 97.40% |
| Dec 31, 2021 | 214.75% |
| Sep 30, 2021 | 311.39% |